BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hopkins SC, Dedic N, Koblan KS. Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans. Transl Psychiatry 2021;11:228. [PMID: 33879769 DOI: 10.1038/s41398-021-01331-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Correll CU, Koblan KS, Hopkins SC, Li Y, Heather Dworak, Goldman R, Loebel A. Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study. NPJ Schizophr 2021;7:63. [PMID: 34887427 DOI: 10.1038/s41537-021-00190-z] [Reference Citation Analysis]
2 Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L. Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia. ACS Med Chem Lett 2022;13:92-8. [PMID: 35047111 DOI: 10.1021/acsmedchemlett.1c00527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chen YL, Shi Y, LaFayette A, Shi L, Koblan KS, Galluppi GR. A sensitive LC-MS/MS method for simultaneous quantification of ulotaront and its N-desmethyl metabolite in human plasma and application to a clinical study. J Pharm Biomed Anal 2022;207:114404. [PMID: 34700199 DOI: 10.1016/j.jpba.2021.114404] [Reference Citation Analysis]
4 Dedic N, Dworak H, Zeni C, Rutigliano G, Howes OD. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies. IJMS 2021;22:13185. [DOI: 10.3390/ijms222413185] [Reference Citation Analysis]
5 Hopkins SC, Ogirala A, Worden M, Koblan KS. Depicting Safety Profile of TAAR1 Agonist Ulotaront Relative to Reactions Anticipated for a Dopamine D2-Based Pharmacological Class in FAERS. Clin Drug Investig 2021;41:1067-73. [PMID: 34751928 DOI: 10.1007/s40261-021-01094-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu Y, Miao Y, Chen X, Wan X. A randomized placebo-controlled double-blind study of dexmedetomidine on postoperative sleep quality in patients with endoscopic sinus surgery. BMC Anesthesiol 2022;22. [DOI: 10.1186/s12871-022-01711-8] [Reference Citation Analysis]
7 Galluppi GR, Polhamus DG, Fisher JM, Hopkins SC, Koblan KS. Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia. CPT Pharmacometrics Syst Pharmacol 2021. [PMID: 34292664 DOI: 10.1002/psp4.12692] [Reference Citation Analysis]
8 Barnes DA, Galloway DA, Hoener MC, Berry MD, Moore CS. TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation. Int J Mol Sci 2021;22:11576. [PMID: 34769007 DOI: 10.3390/ijms222111576] [Reference Citation Analysis]